Description

Piracetam Powder

Piracetam
CAS Number	7491-74-9
Molar Mass	142.158 g·mol−1
Chemical Formula	C6H10N2O2
IUPAC Name	2-(2-Oxopyrrolidin-1-yl)acetamide

Introduction

Piracetam Powder is a widely researched nootropic compound known for its cognitive-enhancing properties. As a subject of numerous scientific investigations, Piracetam has garnered interest for its potential benefits in various cognitive and neurological applications. It is crucial to emphasize that Piracetam Powder is strictly intended for research purposes, and any allusion to human consumption is explicitly prohibited.

Key Characteristics

Piracetam is characterized by its nootropic effects, with research suggesting positive influences on cognitive function and neuroprotection. Its mechanism of action involves the modulation of neurotransmission, making it a focus of studies exploring cognitive disorders and recovery from neurological challenges.

Research Applications

Researchers explore Piracetam Powder in diverse applications within the realm of cognitive and neurological research. Its potential to impact mild cognitive disorders, aid in post-stroke recovery, and influence memory processes makes it a versatile compound for scientific investigations.

Research Benefits

Piracetam and Mild Cognitive Disorders

Studies suggest that Piracetam may have potential benefits for individuals with mild cognitive disorders. Research explores its effects on cognitive function, memory, and overall cognitive well-being.

Piracetam and Post-Stroke Recovery

Piracetam has been studied for its role in post-stroke recovery. Research in this area investigates its neuroprotective properties and potential to support cognitive rehabilitation following a stroke.

Piracetam and Memory

Studies explore the influence of Piracetam on memory processes. Its impact on memory formation, retention, and recall is a subject of interest for researchers examining cognitive enhancement.

Summary

In summary, Piracetam Powder stands as a valuable compound in cognitive and neurological research, showing potential benefits for mild cognitive disorders, post-stroke recovery, and memory enhancement. However, it is crucial to reiterate that Piracetam Powder is exclusively intended for research purposes, and any inference to human consumption is strictly prohibited.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Tariska P, Paksy A. A piracetam tünetjavító hatása enyhe kognitív zavar és demencia tünetcsoportjában szenvedó betegeken [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia]. Orv Hetil. 2000 May 28;141(22):1189-93. Hungarian. PMID: 10853348. [Read More].
2. Enderby P, Broeckx J, Hospers W, Schildermans F, Deberdt W. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study. Clin Neuropharmacol. 1994 Aug;17(4):320-31. doi: 10.1097/00002826-199408000-00003. PMID: 9316679. [Read More].
3. Mindus, P., Cronholm, B., Levander, S.E. and Schalling, D. (1976), Piracetam-induced improvement of mental performance. Acta Psychiatrica Scandinavica, 54: 150-160. https://doi.org/10.1111/j.1600-0447.1976.tb00107.x [Read More].